Imaging is a critical part of clinical R&D, especially in the assessment of therapeutic efficacy of a new treatment and making early go / no go decisions. The use of imaging biomarkers allows making objective decisions on the new drug safety and efficacy sooner, thus reducing overal R&D timelines and costs through effective early phase trials.
We leverage 10 years of expertise in advanced image analysis, global footprint and our proprietary platform Dynamika to accelerate drug development, de-risk trial execution and to ensure integrity and scientific credibility of your data.
Our study teams, led by experienced project managers and equipped with DYNAMIKA’s single-view reporting of the information will closely work with biotech management on the execution of the trial.
We take a holistic approach to the development of a clinical asset: from the strategic positioning, development of a protocol which address the study objectives and the company’s financial health to planning of a bespoke route-to-market, the investment.
Tailored, multi-dimensional views of live trial delivery and real time information access give our clients comfort that the trial is being properly conducted and dramatically accelerates the due diligence process.
We guarantee high level of efficiency in trial delivery achieved through automation of the clinical trial processes, intelligent management of all stakeholders and reduction of human error.
Our experienced team will deliver
For over a decade, we have managed successful engagements for organizations including:
- Biotech—both startups and mature organizations
- Biopharma—seeking to both in-license and out-license
- Device companies—looking to get their product to market
- Not-for-profit organizations sponsoring clinical trials
- Life sciences firms in need of business consulting and funding
- Clinical Research Organizations looking for integration
- Investors and corporate strategic funds seeking opportunities to capture upside value in late-stage drugs
We closely work with many CRO and CMO partners to who share our philosophy of risk sharing with our clients and able to support advanced methodologies for patient stratification, ensure faster enrolment and robust patient retention.